NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions related to heart, lung, blood, and sleep disorders in both adults and children, including preclinical activities necessary for trial implementation. Eligible applicants include independent school districts, public and private higher education institutions, small businesses, various government entities, and nonprofits, among others. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.
Full Description
Description
Eligibility
Eligible applicants
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Government
- Special district governments
- City or township governments
- Federally recognized Native American tribal governments
- Public and Indian housing authorities
- State governments
- County governments
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.